Cardiotoxicity of Cancer Therapies: A Review for the Oncology Provider LIVE
This live webinar has already taken place.
You can watch a recording of the webinar in our video library.
Take any of our Self-Paced, Online Courses and complete an assessment and an evaluation to earn free CE credit*.
*In most cases, Accreditation prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to achieve a score of 80% or better on an assessment for the Self-Paced, Online Course to receive CE credit. Please contact your individual accreditation agencies for more details.
Brian Colwell Jensen, MD, will review the potential cardiotoxicity associated with radiation therapy, chemotherapy, and newer targeted cancer therapies.
These courses are intended for APPs across multidisciplinary cancer care and other professionals.
- Understand that receiving radiation therapy to the chest wall increases the likelihood of subsequently developing cardiovascular disease.
- Know that anthracycline-induced cardiotoxicity still occurs with contemporary dosing regimens and may lead to heart failure.
- Recognize that molecularly targeted cancer therapies, including HER2 antagonists, kinase inhibitors, and immune checkpoint inhibitors are associated with an array of cardiovascular complications.
Please feel free to share the flyer and/or this webpage.
Taking the Course
To continue, click the button Take Course.
If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at firstname.lastname@example.org or (919) 455–1000.
Brian Colwell Jensen, MD
Associate Professor of Medicine
Presenter Disclosure Information
Brian Colwell Jensen, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.
The Greensboro Area Health Education Center is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
- 1.00 NCPD/CNE
- 1.00 Participation